A multi-country comparative study of two treponemal tests for the serodiagnosis of syphilis amongst men who have sex with men (MSM): Chemo-luminescent assay vs Treponema pallidum particle agglutination assay

Lorenzo Gios,Massimo Mirandola,Maddalena Cordioli,Antonella Zorzi,Nigel Sherriff,Jaime Vera,Dominika Wlazly,Mohammed Osman Hassan-Ibrahim,Valeska Padovese,Anabel Darmanin,Rosanna W. Peeling,Magnus Unemo,Karel Blondeel,Igor Toskin
DOI: https://doi.org/10.1186/s12879-024-09100-x
IF: 3.7
2024-03-15
BMC Infectious Diseases
Abstract:International guidelines recommend routine screening for syphilis (aetiological agent: Treponema pallidum subspecies pallidum ) amongst key populations and vulnerable populations using tests detecting treponemal and non-treponemal antibodies. Whilst treponemal tests have high sensitivities and specificities, they differ regarding subjective or objective interpretation, throughput and workload. Chemiluminescence immunoassays (CLIAs) are cost- and time-effective automated methods for detecting treponemal antibodies. The Treponema pallidum particle agglutination assay (TPPA) has been considered the "gold standard" treponemal assay, however, this includes a highly manual procedure, low throughput and subjective interpretation. The present multi-country study evaluated the ADVIA Centaur® Syphilis CLIA (Siemens Healthcare) assay compared to the reference SERODIA-TP·PA® (Fujirebio Diagnostics) for the serodiagnosis of syphilis amongst men who have sex with men (MSM).
infectious diseases
What problem does this paper attempt to address?